Is a Switch From Insulin Therapy to Liraglutide Possible in Japanese Type 2 Diabetes Mellitus Patients?
Author(s) -
Takehiro Kawata,
Akira Kanamori,
Akira Kubota,
Hajime Maeda,
Hikaru Amamiya,
Masahiko Takai,
Hideaki Kaneshige,
Fuyuki Minagawa,
Kotaro Iemitsu,
Mizuki Kaneshiro,
Masashi Ishikawa,
Hiroshi Takeda,
Tetsurou Takuma,
Atsuko Mokubo,
Hideo Machimura,
Mitsuo Obana,
Masaaki Miyakawa,
Yoshikazu Naka,
Daisuke Suzuki,
Yasuo Terauchi,
Masao Toyoda,
Yasushi Tanaka,
Ikuro Matsuba
Publication year - 2014
Publication title -
journal of clinical medicine research
Language(s) - English
Resource type - Journals
eISSN - 1918-3011
pISSN - 1918-3003
DOI - 10.14740/jocmr1719w
Subject(s) - liraglutide , medicine , insulin , diabetes mellitus , type 2 diabetes , discontinuation , type 2 diabetes mellitus , glucagon like peptide 1 receptor , endocrinology , agonist , receptor
To evaluate the efficacy of switching from insulin to the GLP-1 receptor agonist liraglutide in type 2 diabetes mellitus patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom